Hyperandrogenism in Adolescent Girls

    January 2012 in “ Endocrine development ”
    Sophie Catteau-Jonard, Christine Cortet-Rudelli, C Richard-Proust, Didier Dewailly
    Image of study
    TLDR The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.
    The document from 2012 examines the diagnosis and management of hyperandrogenism in adolescent girls, particularly focusing on conditions like PCOS and NCAH. It details the clinical and laboratory assessments necessary for diagnosis, including hormone measurements and the Rotterdam criteria, which require two of the following three for a PCOS diagnosis: oligo/anovulation, signs of hyperandrogenism, and polycystic ovaries, excluding other causes. The document also discusses the pathophysiology of these conditions, the use of ultrasound and anti-Müllerian hormone for defining polycystic ovaries, and the importance of screening for metabolic syndrome in PCOS patients. It recognizes four PCOS phenotypes and differentiates between PCOS and asymptomatic PCO. Additionally, it covers the clinical presentations of NCAH and other hyperandrogenism causes, and outlines treatment options such as oral contraceptives, antiandrogens, weight loss, and cosmetic treatments. The document concludes that a comprehensive approach is essential for diagnosing hyperandrogenism in adolescents and acknowledges the significant psychological and social impact of PCOS due to its symptoms and long-term health implications.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 7 results

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  37 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 1 year ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community Spironolactine Update: 2 months (34, Female)

      in Female  22 upvotes 8 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

    Related Research

    1 / 1 results